Alternatives to Arrakis Bio

A biotechnology company developing precision genetic medicines through base editing technology to treat a broad range of diseases.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

AI-driven digital twin of embryo development for cell-based therapies.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

AI-driven platform for protein-level disease mapping and drug discovery.

AI-powered blood test for early cancer detection and subtyping.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Develops a platform for individual drug customization using aptamers for cancer treatment.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Compressing biology to develop the next generation of therapies.

AI-powered insights platform for life sciences and biotech workflows.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3.